Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
4
×
boston top stories
life sciences
national blog main
boston
clinical trials
national top stories
ally bridge group
alnylam pharmaceuticals
beijing
big data analytics
biotech ipos
blackrock
brii bio
brii biosciences
cancer
casdin capital
china
codiak biosciences
cutaneous t-cell lymphoma
deals
diabetic nephropathy
dyne therapeutics
eventide asset management
exosome
fda
focal segmental glomerulosclerosis
glaxosmithkline
goldfinch bio
gsk
hepatitis b
irving investors
jay ghosh
jazz pharmaceuticals
metacrine
myotonic dystrophy type 1
new york blog main
nonalcoholic steatohepatitis
raleigh-durham
What
medicines
4
×
million
4
×
drug
ipo
new
biosciences
bio’s
brings
company
genetic
raised
adds
alliance
analysis
areas
based
begin
bio
biotech
brii
bring
bubbles
cells
class
clinical
codiak
develop
developing
disease
diseases
disorders
dyne
dyne’s
earlier
employing
exosome
exosomes
formed
fund
goldfinch
Language
unset
Current search:
medicines
×
million
×
" boston blog main "
×
@xconomy.com
3 years ago
Codiak Bio’s IPO Brings In $82M as Exosome Clinical Trials Begin
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
5 years ago
Brii Bio’s Alliance with VBI Vaccines Adds Hepatitis B Drug to Pipeline